ARCHIVES

Contract Authority Expiration Confuses NCI Money Bill Estimates, Which Range From $605 To $650 Million

This article is from The Cancer Letter archive.

Vol. 01 No. 20 | June 21, 1974

Download PDF Visit The Full Archive

Related Articles

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

August 28, 2009

Mack, to Retire, Calls Budget Proposal an “Act of Retreat”

March 19, 1999

New Research Grant Awards

October 18, 1974

NCI Director Halts STELLAR Trial, Seeks “Brilliant Ideas” For Breast Cancer Prevention.

March 2, 2007

Decision To Stop NSABP P-4 Study Before It Starts Shocks Clinical Trialists.

March 2, 2007

ACCC Members Find Few Answers, Many Problems

February 7, 1975